Arrowhead Research Corp (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today presented data at IBC’s 17th Annual TIDES Conference in San Diego on …
Arrowhead Research Corp (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, announced that it completed dosing healthy volunteers and will begin dosing patients …
Arrowhead Research Corp (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, announced that the United States Food and Drug Administration (FDA) informed the …
